The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

Eitemau Tebyg

• Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk?
  gan: van Staa, Tjeerd-Pieter, et al.
  Cyhoeddwyd: (2014)
• Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
  gan: Tjeerd-Pieter van Staa, et al.
  Cyhoeddwyd: (2014-01-01)
• Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
  gan: Matthews, Anthony, et al.
  Cyhoeddwyd: (2016)
• Randomised Evaluations of Accepted Choices in Treatment (REACT) trials: large-scale pragmatic trials within databases of routinely collected electronic healthcare records
  gan: van Staa, Tjeerd-Pieter, et al.
  Cyhoeddwyd: (2011)
• Pragmatic randomised trials using routine electronic health records: putting them to the test
  gan: van Staa, Tjeerd-Pieter, et al.
  Cyhoeddwyd: (2012)